- Molecular Biology
- Review published
- Preprint server
- bioRxiv
Mathéo Lodé
- ORCID iD
- 0009-0004-4673-6352
PREreviews
-
Xavier Guillory, Elodie Lafont, and Mathéo Lodé of the Proteostasis and Cancer Team INSERM U1242 reviewed Engineering ERα degraders with pleiotropic ubiquitin ligase ligands maximizes therapeutic efficacy by co-opting distinct effector ligases